Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mo Yang

Showing results (1641-1650 of 1,672) with videos related to

Pageof 168
Sort By:
The Journal of Invasive Cardiology|July 21, 2022
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Kyoung-Woo Seo, Hyoung-Mo Yang, et al.
Korean Circulation Journal|May 30, 2015
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
The American Journal of Cardiology|September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
Hepatology International|July 17, 2024
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensationJihye Lim, Sung-Eun Kim, Ae Jeong Jo, et al.
Korean Circulation Journal|August 5, 2015
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive PatientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
Clinical and Molecular Hepatology|January 25, 2021
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trialDo Seon Song, Won Kim, Sang Hoon Ahn, et al.
JACC. Cardiovascular Interventions|May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulationYoungjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus InfectionSang Hoon Ahn, Won Kim, Young Kul Jung, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
Clinical and Molecular Hepatology|January 19, 2025
Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized TrialHyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, et al.
Pageof 168

Showing results (1641-1650 of 1,672) with videos related to

Sort By:
Pageof 168
The Journal of Invasive Cardiology|July 21, 2022
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Kyoung-Woo Seo, Hyoung-Mo Yang, et al.
Korean Circulation Journal|May 30, 2015
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
The American Journal of Cardiology|September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
Hepatology International|July 17, 2024
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensationJihye Lim, Sung-Eun Kim, Ae Jeong Jo, et al.
Korean Circulation Journal|August 5, 2015
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive PatientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
Clinical and Molecular Hepatology|January 25, 2021
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trialDo Seon Song, Won Kim, Sang Hoon Ahn, et al.
JACC. Cardiovascular Interventions|May 22, 2010
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulationYoungjin Cho, Han-Mo Yang, Kyung-Woo Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus InfectionSang Hoon Ahn, Won Kim, Young Kul Jung, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
Clinical and Molecular Hepatology|January 19, 2025
Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized TrialHyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, et al.
Pageof 168